Resolution Therapeutics: Valuation, Funding & Investors
Resolution Therapeutics is a biotechnology company focused on developing engineered, pro-regenerative macrophage therapies for the treatment of end-stage liver disease and other inflammatory and fibrotic conditions. The company aims to advance its lead asset, RTX001, which holds first-in-class potential, through clinical trials while expanding its pipeline and manufacturing capabilities.
Leadership & Board
- Current Number of Employees
- 75
- Current LinkedIn Followers
- 12,309
Latest Estimated Valuation
- Total Amount Raised
- $64M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $64M
- Latest Funding Round
- Series B
Company Momentum
PositiveResolution Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Resolution Therapeutics had 75 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Resolution Therapeutics had 12,309 followers as of November 16, 2026. The number of followers increased by 58 (0.47%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $63.50M | ― |
Similar Companies
A snapshot of private companies similar to Resolution Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis








